Revenue from Contracts with Customers (Tables)

9 Months Ended

Sep. 24, 2021

Disaggregation of Revenue [Line Items]

The following table reflects activity in the Company's sales reserve accounts:


	Rebates and Chargebacks		Product Returns		Other Sales Deductions		Total
Balance as of December 27, 2019	$	295.8	$	28.4	$	13.2	$	337.4
Provisions	1,453.7		22.3		44.3		1,520.3
Provision for Medicaid lawsuit (Note 12) (1)	535.1		—		—		535.1
Payments or credits	(1,461.3)		(24.3)		(45.8)		(1,531.4)
Balance as of September 25, 2020	$	823.3	$	26.4	$	11.7	$	861.4

Balance as of December 25, 2020	$	196.5	$	26.6	$	12.3	$	235.4
Provisions	1,588.6		18.2		42.5		1,649.3


Payments or credits	(1,535.7)		(23.5)		(32.6)		(1,591.8)
Balance as of September 24, 2021	$	249.4	$	21.3	$	22.2	$	292.9

(1)Excludes the $105.1 million that is reflected as a component of operating expenses as it represents a pre-acquisition contingency related to the portion of the liability that arose from sales of Acthar Gel prior to the Company's acquisition of Questcor Pharmaceuticals Inc. ("Questcor") in August 2014. See Note 12 for further detail on the status of the Medicaid lawsuit.

Disaggregation of Revenue

Product sales transferred to customers at a point in time and over time were as follows:


	Three Months Ended				Nine Months Ended
	September 24, 2021		September 25, 2020		September 24, 2021		September 25, 2020
Product sales transferred at a point in time	80.3	%	79.5	%	78.7	%	78.5	%
Product sales transferred over time	19.7		20.5		21.3		21.5

The associated royalty revenue recognized was as follows:


	Three Months Ended				Nine Months Ended
	September 24, 2021		September 25, 2020		September 24, 2021		September 25, 2020
Royalty revenue	$	27.3	$	20.4	$	82.2	$	52.3

Contract with Customer, Timing of Satisfaction of Performance Obligation and Payment

The following table includes estimated revenue from contracts extending greater than one year for certain of the Company's hospital products that are expected to be recognized in the future related to performance obligations that were unsatisfied or partially unsatisfied as of September 24, 2021:


Remainder of Fiscal 2021	$	35.6
Fiscal 2022	106.4
Fiscal 2023	64.4
Thereafter	14.7